Skip to main content
Erschienen in: World Journal of Urology 5/2013

01.10.2013 | Original Article

Evaluation of the learning curve for Thulium VapoEnucleation of the prostate (ThuVEP) using a mentor-based approach

verfasst von: C. Netsch, T. Bach, T. R. W. Herrmann, O. Neubauer, A. J. Gross

Erschienen in: World Journal of Urology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Introduction

To evaluate the learning curve of Thulium:YAG VapoEnucleation of the prostate (ThuVEP) for patients with symptomatic benign prostatic obstruction (BPO) prospectively.

Methods

ThuVEP was performed using the 120 Watt 2 μm continuous wave Thulium:YAG laser. ThuVEP was done by a resident without experience in transurethral prostate surgery (A, n = 32), an experienced endourologist (B, n = 32), and an experienced surgeon in ThuVEP (C, n = 32), who served as the mentor for A/B. Patients were divided into consecutive subgroups of 8 patients to assess the impact of the learning curve on procedure outcome. Patient demographic, perioperative, and 12-month follow-up data were analysed.

Results

ThuVEP was successfully completed in all patients. Enucleation efficiency (g/min) differed significantly between surgeon A (0.48 ± 0.3), B (0.7 ± 0.36), and C (1.4 ± 0.67) (p ≤ 0.001). Enucleation efficiency correlated significantly with the weight of resected tissue in surgeon A (r = 0.88), B (r = 0.73), and C (r = 0.79) (p < 0.001). ThuVEP was performed by surgeon A and B with reasonable enucleation, morcellation, and overall operation efficiency after 8–16 procedures. At 12-month follow-up, 68 (71 %) patients were available for review. IPSS, QoL, Qmax, PVR, PSA, and prostate volume improved significantly at follow-up (p ≤ 0.023). Mean PSA/prostate volume reduction was 81.95/74.5, 80.7/79.4, and 87.6/75.9 % in surgeon A, B, and C, respectively. Urethral stricture and bladder neck contracture developed 2 (A = 1, B = 1; 2.1 %) patients and 1 (C, 1 %) patient each, respectively.

Conclusions

ThuVEP can be performed with reasonable efficiency even during the initial learning course of the surgeon when closely mentored. Previous experience in the field of endourology is beneficial.
Literatur
1.
Zurück zum Zitat Kuntz RM, Lehrich K, Ahyai SA (2008) Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 g: 5-year follow-up results of a randomised clinical trial. Eur Urol 53:160–168PubMedCrossRef Kuntz RM, Lehrich K, Ahyai SA (2008) Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 g: 5-year follow-up results of a randomised clinical trial. Eur Urol 53:160–168PubMedCrossRef
2.
Zurück zum Zitat Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R, Cestari A, Briganti A, Mazzoccoli B, Rigatti P, Montorsi F (2006) Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol 50:563–568PubMedCrossRef Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R, Cestari A, Briganti A, Mazzoccoli B, Rigatti P, Montorsi F (2006) Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol 50:563–568PubMedCrossRef
3.
Zurück zum Zitat Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CG (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58:384–397PubMedCrossRef Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CG (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58:384–397PubMedCrossRef
4.
Zurück zum Zitat Naspro R, Bachmann A, Gilling P, Kuntz R, Madersbacher S, Montorsi F, Reich O, Stief C, Vavassori I (2009) A review of recent evidence (2006–2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate. Eur Urol 55:1345–1357PubMedCrossRef Naspro R, Bachmann A, Gilling P, Kuntz R, Madersbacher S, Montorsi F, Reich O, Stief C, Vavassori I (2009) A review of recent evidence (2006–2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate. Eur Urol 55:1345–1357PubMedCrossRef
5.
Zurück zum Zitat Moody JA, Lingeman JE (2001) Holmium laser enucleation for prostate adenoma greater than 100 g.: comparison to open prostatectomy. J Urol 165:459–462PubMedCrossRef Moody JA, Lingeman JE (2001) Holmium laser enucleation for prostate adenoma greater than 100 g.: comparison to open prostatectomy. J Urol 165:459–462PubMedCrossRef
6.
Zurück zum Zitat Kuntz RM, Lehrich K (2002) Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 g.: a randomized prospective trial of 120 patients. J Urol 168:1465–1469PubMedCrossRef Kuntz RM, Lehrich K (2002) Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 g.: a randomized prospective trial of 120 patients. J Urol 168:1465–1469PubMedCrossRef
7.
Zurück zum Zitat El-Hakim A, Elhilali MM (2002) Holmium laser enucleation of the prostate can be taught: the first learning experience. BJU Int 90:863–869PubMedCrossRef El-Hakim A, Elhilali MM (2002) Holmium laser enucleation of the prostate can be taught: the first learning experience. BJU Int 90:863–869PubMedCrossRef
8.
Zurück zum Zitat Shah HN, Mahajan AP, Sodha HS, Hegde S, Mohile PD, Bansal MB (2007) Prospective evaluation of the learning curve for holmium laser enucleation of the prostate. J Urol 177:1468–1474PubMedCrossRef Shah HN, Mahajan AP, Sodha HS, Hegde S, Mohile PD, Bansal MB (2007) Prospective evaluation of the learning curve for holmium laser enucleation of the prostate. J Urol 177:1468–1474PubMedCrossRef
9.
Zurück zum Zitat Bach T, Wendt-Nordahl G, Michel MS, Herrmann TRW, Gross AJ (2009) Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol 27:541–545PubMedCrossRef Bach T, Wendt-Nordahl G, Michel MS, Herrmann TRW, Gross AJ (2009) Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol 27:541–545PubMedCrossRef
10.
Zurück zum Zitat Bach T, Netsch C, Haecker A, Michel MS, Herrmann TR, Gross AJ (2010) Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol 28:39–43PubMedCrossRef Bach T, Netsch C, Haecker A, Michel MS, Herrmann TR, Gross AJ (2010) Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol 28:39–43PubMedCrossRef
11.
12.
Zurück zum Zitat Bach T, Huck N, Wezel F, Häcker A, Gross AJ, Michel MS (2010) 70 versus 120 W thulium:yttrium-aluminium-garnet 2 microm continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex vivo evaluation. BJU Int 106:368–372PubMedCrossRef Bach T, Huck N, Wezel F, Häcker A, Gross AJ, Michel MS (2010) 70 versus 120 W thulium:yttrium-aluminium-garnet 2 microm continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex vivo evaluation. BJU Int 106:368–372PubMedCrossRef
13.
Zurück zum Zitat Matlaga BR, Kim SC, Kuo RL, Watkins SL, Lingeman JE (2006) Holmium laser enucleation of the prostate for prostates of >125 ml. BJU Int 97:81–84PubMedCrossRef Matlaga BR, Kim SC, Kuo RL, Watkins SL, Lingeman JE (2006) Holmium laser enucleation of the prostate for prostates of >125 ml. BJU Int 97:81–84PubMedCrossRef
14.
Zurück zum Zitat Peterson MD, Matlaga BR, Kim SC, Kuo RL, Soergel TM, Watkins SL, Lingeman JE (2005) Holmium laser enucleation of the prostate for men with urinary retention. J Urol 174:998–1001PubMedCrossRef Peterson MD, Matlaga BR, Kim SC, Kuo RL, Soergel TM, Watkins SL, Lingeman JE (2005) Holmium laser enucleation of the prostate for men with urinary retention. J Urol 174:998–1001PubMedCrossRef
15.
Zurück zum Zitat Kuo RL, Kim SC, Lingeman JE, Paterson RF, Watkins SL, Simmons GR, Steele RE (2003) Holmium laser enucleation of prostate (HoLEP): the Methodist Hospital experience with greater than 75 g enucleations. J Urol 170:149–152PubMedCrossRef Kuo RL, Kim SC, Lingeman JE, Paterson RF, Watkins SL, Simmons GR, Steele RE (2003) Holmium laser enucleation of prostate (HoLEP): the Methodist Hospital experience with greater than 75 g enucleations. J Urol 170:149–152PubMedCrossRef
16.
Zurück zum Zitat Seki N, Mocida O, Kinukawa N, Sagiyama K, Nato S (2003) Holmium laser enucleation for prostatic adenoma: analysis of learning curve over the curse of 70 consecutive cases. J Urol 170:1847–1850PubMedCrossRef Seki N, Mocida O, Kinukawa N, Sagiyama K, Nato S (2003) Holmium laser enucleation for prostatic adenoma: analysis of learning curve over the curse of 70 consecutive cases. J Urol 170:1847–1850PubMedCrossRef
17.
Zurück zum Zitat Placer J, Gelabert-Mas A, Vallmanya F, Manresa JM, Mene´ndez V, Cortadellas R, Arango O (2009) Holmium laser enucleation of prostate: outcome and complications of self-taught learning curve. Urology 73:1042–1048PubMedCrossRef Placer J, Gelabert-Mas A, Vallmanya F, Manresa JM, Mene´ndez V, Cortadellas R, Arango O (2009) Holmium laser enucleation of prostate: outcome and complications of self-taught learning curve. Urology 73:1042–1048PubMedCrossRef
18.
Zurück zum Zitat Du C, Jin X, Bai F, Qiu Y (2008) Holmium laser enucleation of the prostate: the safety, efficacy, and learning experience in China. J Endourol 22:1031–1036PubMedCrossRef Du C, Jin X, Bai F, Qiu Y (2008) Holmium laser enucleation of the prostate: the safety, efficacy, and learning experience in China. J Endourol 22:1031–1036PubMedCrossRef
19.
Zurück zum Zitat Bach T, Herrmann TR, Ganzer R, Burchardt M, Gross AJ (2007) RevoLix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up. World J Urol 25:257–262PubMedCrossRef Bach T, Herrmann TR, Ganzer R, Burchardt M, Gross AJ (2007) RevoLix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up. World J Urol 25:257–262PubMedCrossRef
20.
Zurück zum Zitat Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, Zhang YN (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53:382–389PubMedCrossRef Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, Zhang YN (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53:382–389PubMedCrossRef
21.
Zurück zum Zitat Fu WJ, Zhang X, Yang Y, Hong BF, Gao JP, Cai W, Zhang P, Wang XX (2010) Comparison of 2-microm continuous wave laser vaporesection of the prostate and transurethral resection of the prostate: a prospective nonrandomized trial with 1-year follow-up. Urology 75:194–199PubMedCrossRef Fu WJ, Zhang X, Yang Y, Hong BF, Gao JP, Cai W, Zhang P, Wang XX (2010) Comparison of 2-microm continuous wave laser vaporesection of the prostate and transurethral resection of the prostate: a prospective nonrandomized trial with 1-year follow-up. Urology 75:194–199PubMedCrossRef
22.
Zurück zum Zitat Shah HN, Mahajan AP, Hegde SS, Bansal MB (2007) Peri-operative complications of holmium laser enucleation of the prostate: experience in the first 280 patients, and a review of literature. BJU Int 100:94–101PubMedCrossRef Shah HN, Mahajan AP, Hegde SS, Bansal MB (2007) Peri-operative complications of holmium laser enucleation of the prostate: experience in the first 280 patients, and a review of literature. BJU Int 100:94–101PubMedCrossRef
23.
Zurück zum Zitat Aho TF, Gilling PJ, Kennett KM, Westenberg AM, Fraundorfer MR, Frampton CM (2005) Holmium laser bladder neck incision versus holmium enucleation of the prostate as outpatient procedures for prostates less than 40 g: a randomized trial. J Urol 174:210–214PubMedCrossRef Aho TF, Gilling PJ, Kennett KM, Westenberg AM, Fraundorfer MR, Frampton CM (2005) Holmium laser bladder neck incision versus holmium enucleation of the prostate as outpatient procedures for prostates less than 40 g: a randomized trial. J Urol 174:210–214PubMedCrossRef
Metadaten
Titel
Evaluation of the learning curve for Thulium VapoEnucleation of the prostate (ThuVEP) using a mentor-based approach
verfasst von
C. Netsch
T. Bach
T. R. W. Herrmann
O. Neubauer
A. J. Gross
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 5/2013
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-012-0894-1

Weitere Artikel der Ausgabe 5/2013

World Journal of Urology 5/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.